SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-058714
Filing Date
2015-08-11
Accepted
2015-08-11 16:06:08
Documents
3
Period of Report
2015-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-17280_18k.htm 8-K 40425
2 EX-99.1 a15-17280_1ex99d1.htm EX-99.1 82875
3 GRAPHIC g172801mmi001.jpg GRAPHIC 4155
  Complete submission text file 0001104659-15-058714.txt   130670
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 151043950
SIC: 2834 Pharmaceutical Preparations